Phase II Trial of Weekly or Bi-Weekly Tocilizumab with Ipilimumab and Nivolumab in Advanced Melanoma: Clinical Outcomes and Biomarker Analysis.
Journal of Clinical Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined